ELSI's reputation for quality expertise and the complementarity of its partners in their experience and practice in pharmaceutical business and regulatory affairs, also deploys its full power in litigation and product liability matters.
Thanks to their perfect knowledge of the sector, ELSI's lawyers are involved in both amicable and emergency procedures or in substantive matters:
- in national and European administrative litigation on health products, combining their experience in health authorities, laboratories and firms dedicated to the health industries,
- in judicial litigation, where they have acquired significant and recognised know-how in commercial disputes (parasitism, denigration, misleading commercial practices, violation of advertising rules..) and in product liability cases (drugs, vaccines, medical devices). They also assist their clients in CCI and expertise procedures,
- in ordinal and disciplinary procedures, accompanying pharmacists and pharmacists' representatives.
Providing a complete and global support, as close as possible to the expectations of its clients, ELSI also intervenes in crisis management and reputational risk.
Based on this practice and with a taste for sharing, ELSI's partners teach health police and liability litigation at the University of Paris and raise awareness among pharmaceutical operators through their publications and training activities on the issues at stake in their activities and their responsibilities as well as on the consequences of case law developments on their practice.
Cultivating a modern approach and a field expertise, in order to respond as closely as possible to the needs of their clients, ELSI's lawyers bring a strategic perspective to all the cases in which they intervene, not hesitating to adopt an offensive approach when necessary.
Passionate lawyers and strategists, the firm strives to defend its clients' interests in the context of a transaction or an administrative or judicial procedure, by combining and mobilising all its skills, thus enabling the determination of complete and innovative strategies.
As a true partner of its clients, ELSI is committed to a transparent and predictable fee policy in matters of litigation and dispute management.
Marketing, advertising, health police, establishments, anti-gift & transparency+
Contract law, commercial, advertising, distribution, restrictive practices, anti-competitive practices+
RGDP, CNIL methodology, health data hosting, securing contracts, support for digital projects+
Legal and regulatory updates, skills upgrading, find out about all our customised training offers+
Our outsourcing offer, the subcontracting of your anti-gift activities & health transparency+
Subscriptions, regulatory advice, audit packages, find all our subscription and subcontracting offers+
Transformation, temporary surge, implementation of new processes or crisis management+
An investigation by the DGCCRF in 2021 led to the penalization of 6.6 million euros for illegal practices by the URGO group.
Medical device law
An amendment to the WDR has just been proposed by the European Commission to postpone the entry into force of the WDR.